Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "BD"

233 News Found

KKR to invest in life sciences firm Catalio Capital Management
News | October 23, 2023

KKR to invest in life sciences firm Catalio Capital Management

Investment is additive to KKR’s existing health care growth strategy


USFDA approves Pfizer’s Velsipity for adults with Ulcerative Colitis
Drug Approval | October 20, 2023

USFDA approves Pfizer’s Velsipity for adults with Ulcerative Colitis

Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials


Sun Pharma Canada launches Prwinlevi for treatment for acne
News | September 28, 2023

Sun Pharma Canada launches Prwinlevi for treatment for acne

WINLEVI works differently from any other topical acne treatment


27,353 hospitals empanelled under PM-JAY
Policy | September 26, 2023

27,353 hospitals empanelled under PM-JAY

30 beneficiaries avail of services per minute


Arogya Manthan 2023 to mark 5 years of Ayushman Bharat PM-JAY
Policy | September 25, 2023

Arogya Manthan 2023 to mark 5 years of Ayushman Bharat PM-JAY

National Health Authority (NHA) to host the two-day Arogya Manthan event in New Delhi


Fortis Bannerghatta conducts Karnataka's first pediatric robot-assisted surgery
Healthcare | September 20, 2023

Fortis Bannerghatta conducts Karnataka's first pediatric robot-assisted surgery

The complexity of operating on a one-year-old are many with the organs being tiny, fragile


Bayer appoints Dr. Juergen Eckhardt as new Head of Pharmaceuticals Business Development & Licensing/Open Innovation
People | August 29, 2023

Bayer appoints Dr. Juergen Eckhardt as new Head of Pharmaceuticals Business Development & Licensing/Open Innovation

Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer


Jemperli plus chemotherapy approved in the US as the first new frontline treatment option for dMMR/MSI-H primary advanced or recurrent endometrial cancer
Drug Approval | August 01, 2023

Jemperli plus chemotherapy approved in the US as the first new frontline treatment option for dMMR/MSI-H primary advanced or recurrent endometrial cancer

Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy


CARER collaborates with Wholeleaf to enhance holistic cancer care services
News | July 17, 2023

CARER collaborates with Wholeleaf to enhance holistic cancer care services

The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being


Healthium Medtech appoints Dr. Vivek S. Iyer as GM for Professional Education & Market Growth Strategy
People | July 05, 2023

Healthium Medtech appoints Dr. Vivek S. Iyer as GM for Professional Education & Market Growth Strategy

Dr. Vivek joins Healthium after a stint at Ethicon, Johnson & Johnson